Cargando…
Efficacy and safety of anti-vascular endothelial growth factor therapies in older patients for first line treatment of metastatic renal cell carcinoma
BACKGROUND: immunotherapy became the first line treatment of metastatic renal cell carcinoma (mRCC). Nevertheless, a better understanding of the specificities of targeted therapies (TT) in the elderly population could be helpful in order to improve the management of mRCC in this population. The aim...
Autores principales: | Dupuis, Hugo Georges Arthur, Chebbi, Ala, Surlemont, Louis, Rigal, Olivier, Di Fiore, Frédéric, Pfister, Christian, Nouhaud, François-Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261413/ https://www.ncbi.nlm.nih.gov/pubmed/34295728 http://dx.doi.org/10.21037/tau-20-1481 |
Ejemplares similares
-
Impact du COVID-19 sur l’activité chirurgicale urologique dans les établissements de santé publics et privés sur le territoire national français entre 2019 et 2021
por: Brument, M., et al.
Publicado: (2022) -
Differential impact of COVID-19 on urological surgeries in public and private institutions between 2019 and 2021 in France
por: Brument, M., et al.
Publicado: (2023) -
Evolution of prostate cancer diagnosis: retrospective analysis of magnetic resonance imaging/ultrasound fusion guided biopsies protocol in routine practice and patients management
por: Essid, Mohamed Ali, et al.
Publicado: (2020) -
Advantages of an Intracorporeal W-shaped Neobladder
por: Nouhaud, François-Xavier, et al.
Publicado: (2021) -
Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib
por: Di Fiore, F, et al.
Publicado: (2011)